Billerud expands medical paper portfolio with the launch of a new high-quality surface treated medical paper – MediKraft SealBase

“MediKraft SealBase demonstrates our commitment to the medical segment and providing innovative solutions to our customers. This is a strategic step in broadening Billerud's product portfolio in medical paper, allowing us to cater to a wider range of medical applications and customers seeking alternatives to traditional latex-based cold seal products,” says Robert Torstensson, Vice President, Business Area Paper at Billerud.

Produced at Billerud’s Skärblacka mill in Sweden and made of pure virgin fiber, the 38 gsm grade MediKraft SealBase is the first product being released in this range. It is tailored to be a base paper for medical synthetic cold seal coatings, offering an innovative solution for medical applications where a sterile barrier system is not required – ideally suited for applications such as plaster and it also holds potential for use with latex-based cold seal coatings.

“An integrated pulp production ensures complete control of the manufacturing process, supported by comprehensive quality control systems. MediKraft SealBase also offers a competitive edge through our advanced sustainability credentials, solidifying our reputation as a trusted partner in providing high-quality, environmentally responsible medical paper products,” says Robert Torstensson.

Billerud has over 50 years of expertise in producing world-class medical papers, supplying their two main categories of medical paper globally – SteriKraft and MediKraft. Billerud SteriKraft is a range of clean and safe microbial barrier medical paper – suitable for various sterilization methods – ensuring sterility and purity until the point of use. Billerud MediKraft is a range of strong, high-purity papers for applications that don’t require microbial barrier properties such as inner wrapping of single-use gloves, plaster packaging and examination table covers.

MediKraft SealBase key facts and information:

• Safe: With integrated pulp production, Billerud ensures complete control of the manufacturing process, supported by comprehensive quality control systems. No Optical Brightening Agents (OBA) are used in the production, and quality is monitored with advanced tools like Web Inspection Systems (WIS) and in-house bioburden labs. Full traceability further ensures product safety. It is tested for various sterilization methods, including E-Beam, gamma, EO, and steam, ensuring broad compatibility with industry requirements.
• Pure: Made from 100 percent virgin fiber, MediKraft SealBase maintains high purity through controlled bioburden and cytotoxicity testing. The absence of OBA, latex, and recycled fibers enhances the product's suitability for medical applications.
• High performing: MediKraft SealBase is strong and thereby offers excellent runnability enabling efficient conversion processes. The smooth MG (machine-glazed) side improves printability.
• Sustainability: As a recyclable product, MediKraft SealBase supports Billerud's commitment to reducing environmental impact. With low CO2 emissions in production, Billerud is among the leaders in sustainable practices within the medical packaging industry. Moreover, Billerud is currently the only company in the market that consistently produces and discloses Environmental Product Declarations (EPDs) for nearly all its medical paper products with the aim of extending this transparency to cover 100 percent of the product line in the near future.
  
  

For more information about MediKraft SealBase or to request samples, please visit www.billerud.com/medical.